** Shares of medical device maker Inari Medical rise ~7% to $45.56 premarket
** Inari, late on Monday, raised the lower end of its full year 2024 revenue forecast to $601.5 million to $604.5 million, from its prior range of $594.5 million to $604.5 million
** Co's Q3 revenue of $153.39 mln beats analysts' average expectation of $150.67 mln - LSEG
** Co continues to expect to reach sustained operating profitability in first half of 2025
** At least two analysts have raised co's PT after results
** Up to last close, stock down 34.4% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。